No results for ‘’
Senores Pharmaceuticals Ltd
NSE: SENORES BSE: 544319
₹1290
(11.14%)
Wed, 24 Jun 2026, 02:43 am
Market Cap (in Cr)5946.67
PE Ratio49.33
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSenores Pharmaceuticals Financials
| Particulars | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total revenue | 140.68M | 353.26M | 2.14B | 3.97B |
| Gross profit | 24.68M | 159.88M | 540.70M | 1.21B |
| Operating expenses (excl. COGS) | -13.23M | -50.25M | -230.20M | -486.90M |
| Selling/general/admin expenses, total | -13.09M | -49.87M | -225.10M | -458.90M |
| Research & development | — | — | — | -4.90M |
| Selling/general/admin expenses, other | -13.09M | -49.87M | -225.10M | -454.00M |
| Other operating expenses, total | -140.00K | -380.00K | -5.10M | -28.00M |
| Operating income | 11.45M | 109.63M | 310.50M | 719.80M |
| Non-operating income, total | -20.00K | 14.74M | -61.10M | -14.10M |
| Interest expense, net of interest capitalized | -5.50M | -20.87M | -94.00M | -215.20M |
| Interest capitalized | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 5.48M | 35.61M | 32.90M | 201.10M |
| Non-operating interest income | 1.93M | 390.00K | 4.60M | 71.60M |
| Miscellaneous non-operating expense | 3.55M | 35.22M | 28.30M | 129.50M |
| Unusual income/expense | 0 | 0 | 0 | 0 |
| Pretax income | 11.43M | 124.37M | 249.40M | 705.70M |
| Taxes | -1.52M | -40.04M | 77.70M | -122.30M |
| Non-controlling/minority interest | 0 | 0 | -12.50M | 2.20M |
| After tax other income/expense | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 9.91M | 84.33M | 314.60M | 585.60M |
| Net income | 9.91M | 84.33M | 314.60M | 585.60M |
| Dilution adjustment | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 9.91M | 84.33M | 314.60M | 585.60M |
| Basic earnings per share (Basic EPS) | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - |
| EBITDA | 18.50M | 127.42M | 410.70M | 888.20M |
| EBIT | 11.45M | 109.63M | 310.50M | 719.80M |
| Total operating expenses | -129.23M | -243.63M | -1.83B | -3.25B |
| Prepaid expenses | 140.00K | 12.02M | 30.30M | 72.10M |
| Deferred income, current | — | — | 9.30M | 9.60M |
| Capital and operating lease obligations | 4.07M | 15.83M | 82.00M | 82.00M |
| Operating lease liabilities | — | — | — | — |
| Deferred tax liabilities | 3.11M | 20.96M | 228.00M | 190.80M |
| Deferred income, non-current | — | — | — | — |
| Minority interest | 0 | 0 | 274.40M | 260.60M |
| Change in accrued expenses | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 |